Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pediatric rheumatology

JIA, treatment and possible risk of malignancies

Nature Reviews Rheumatology volume 7, pages 6–7 (2011)Cite this article

Subjects

The effect of biological therapies on cancer risk in JIA is controversial owing to confounding factors such as the use of concomitant immunosuppressants. A study has shed new light on this association, but questions still remain on the effect of the disease itself and biological therapies on cancer risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Martini, A. & Lovell, D. J. Juvenile idiopathic arthritis: state of the art and future perspectives. Ann. Rheum. Dis. 69, 1260–1263 (2010).

    Article  Google Scholar 

  2. FDA. Early communication about an ongoing safety review of tumor necrosis factor (TNF) blockers (marketed as remicade, enbrel, humira, and cimzia). http://www.fda.gov/[online], (2008).

  3. Diak, P. et al. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 62, 2517–2524 (2010).

    Article  Google Scholar 

  4. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964–975 (2010).

    Article  CAS  Google Scholar 

  5. Cabral, D. A. & Tucker, L. B. Malignancies in children who initially present with rheumatic complaints. J. Pediatr. 134, 53–57 (1999).

    Article  CAS  Google Scholar 

  6. Lehman, T. J. Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis? Arthritis Rheum. 62, 2183–2184 (2010).

    Article  Google Scholar 

  7. Simard, J., Neovius, M., Hagelberg, S. & Askling, J. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum. doi:10.1002/art.27741.

  8. Truckenbrodt, H. & Häfner, R. Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study. Arthritis Rheum. 29, 801–807 (1986).

    Article  CAS  Google Scholar 

  9. Paediatric Rheumatology European Society [online], (2010).

  10. Ruperto, N. & Martini, A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr. Opin. Rheumatol. 16, 566–570 (2004).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IRCCS G Gaslini, Pediatria II Reumatologia, PRINTO, Università di Genova, Largo Gaslini 5, 16147, Genova, Italy

    Nicolino Ruperto & Alberto Martini

Authors
  1. Nicolino Ruperto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolino Ruperto.

Ethics declarations

Competing interests

The authors are on the speaker's bureau for Bristol-Myers Squibb and Novartis, while N. Ruperto is also on the speaker's bureau for Roche. A. Martini and N. Ruperto are Chairman and Senior Scientist, respectively, for the Pediatric Rheumatology International Trials Organisation (PRINTO), a non-profit organization that receives grant/research support from Abbott, Acraf S.p.A., Bristol-Myers Squibb, Centocor Ortho Biotech, Novartis, Pfizer, Roche and Xoma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruperto, N., Martini, A. JIA, treatment and possible risk of malignancies. Nat Rev Rheumatol 7, 6–7 (2011). https://doi.org/10.1038/nrrheum.2010.199

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2010.199

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing